Institution · Vitos

Most cited papers from Vitos

Vitos

What are the most cited papers from Vitos?

The most cited paper from Vitos is "Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017" (Christoph Hiemke et al., 2017), with 1,453 citations. Next come "Induction of self awareness in dreams through frontal low current stimulation of gamma activity" (348) and "The cannabis withdrawal syndrome: current insights" (224).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 59 papers. Every paper with more than 33 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017 Christoph Hiemke et al. · Pharmacopsychiatry Open access	14 Sep 2017	1,453
2	Induction of self awareness in dreams through frontal low current stimulation of gamma activity Ursula Voss, Romain Holzmann, Allan J. Hobson et al. · Nature Neuroscience	11 May 2014	348
3	The cannabis withdrawal syndrome: current insights Udo Bonnet, Ulrich W. Preuss · Substance Abuse and Rehabilitation Open access	Apr 2017	224
4	Acne and quality of life – impact and management Uwe Gieler, Tanja Gieler, JP. Kupfer · Journal of the European Academy of Dermatology and Venereology Open access	Jun 2015	189
5	A rating scale for the assessment of objective and subjective formal Thought and Language Disorder (TALD) Tilo T. J. Kircher, Axel Krug, Mirjam Stratmann et al. · Schizophrenia Research Open access	17 Nov 2014	166
6	Measuring consciousness in dreams: The lucidity and consciousness in dreams scale Ursula Voss, Karin Schermelleh-Engel, Jennifer Windt et al. · Consciousness and Cognition	4 Dec 2012	156
7	TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians Georgios Schoretsanitis et al. · The World Journal of Biological Psychiatry	Mar 2018	150
8	Autism spectrum disorders, endocrine disrupting compounds, and heavy metals in amniotic fluid: a case-control study Manhai Long, Mandana Ghisari, Lisbeth Stigaard Kjeldsen et al. · Molecular Autism Open access	9 Jan 2019	133
9	Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations Anja Cerovecki, Richard Musil, Ansgar Klimke et al. · CNS Drugs	Jul 2013	111
10	Standards für die Behandlung im Maßregelvollzug nach §§ 63 und 64 StGB J. L. Müller et al. · Der Nervenarzt Open access	Aug 2017	104
11	Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: mega-analytic findings from a large multi-site cohort Leonardo Tozzi et al. · Psychological Medicine Open access	14 May 2019	104
12	Cannabis Use and Car Crashes: A Review Ulrich W. Preuss, Marilyn Ann Huestis, Miriam Schneider et al. · Frontiers in Psychiatry Open access	28 May 2021	94
13	Body dysmorphia in common skin diseases: results of an observational, cross‐sectional multicentre study among dermatological outpatients in 17 European countries* Christina Schut et al. · British Journal of Dermatology Open access	18 Jan 2022	90
14	Insulin sensitivity predicts cognitive decline in individuals with prediabetes Caroline Willmann, Kathrin Brockmann, Robert J. Wagner et al. · BMJ Open Diabetes Research & Care Open access	Nov 2020	87
15	Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study Frank Petrak, Stephan Herpertz, Christian Albus et al. · Diabetes Care	17 Feb 2015	83
16	Shared genetic risk between eating disorder‐ and substance‐use‐related phenotypes: Evidence from genome‐wide association studies Melissa A. Munn‐Chernoff et al. · Addiction Biology Open access352 authors	16 Feb 2020	75
17	Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries Sylvia van Beugen et al. · Acta Dermato Venereologica Open access	22 Jun 2023	73
18	Comorbid Bipolar and Alcohol Use Disorder—A Therapeutic Challenge Heinz Grunze, Martin Schaefer, Harald Scherk et al. · Frontiers in Psychiatry Open access	23 Mar 2021	73
19	New Clinically Relevant Findings about Violence by People with Schizophrenia Sheilagh Hodgins, Sanja Klein · The Canadian Journal of Psychiatry Open access	11 Jul 2016	67
20	Who stays, who benefits? Predicting dropout and change in cognitive behaviour therapy for psychosis Tania M. Lincoln, Winfried Rief, Stefan Westermann et al. · Psychiatry Research Open access	19 Feb 2014	65
21	Distinct Neuropsychological Correlates in Positive and Negative Formal Thought Disorder Syndromes: The Thought and Language Disorder Scale in Endogenous Psychoses Arne Nagels, Paul Fährmann, Mirjam Stratmann et al. · Neuropsychobiology	2016	64
22	Changes in German Mental Health Care by Implementing a Global Treatment Budget—A Mixed-Method Process Evaluation Study Julian Schwarz, Laura Galbusera, Andreas Bechdolf et al. · Frontiers in Psychiatry Open access	25 May 2020	63
23	The cross-sectional GRAS sample: A comprehensive phenotypical data collection of schizophrenic patients Katja Ribbe et al. · BMC Psychiatry Open access	10 Nov 2010	63
24	The effects of recovery sleep on pain perception: A systematic review Cindy Stroemel-Scheder, Bernd Kundermann, Stefan Lautenbacher · Neuroscience & Biobehavioral Reviews Review	7 Apr 2020	62
25	Widespread microglial activation in multiple system atrophy Dorothee Kübler, Tobias Wächter, Nicole Cabanel et al. · Movement Disorders Open access	6 Feb 2019	61
26	S2k guideline: Rosacea Benjamin Maximilian Clanner-Engelshofen, Dominik Bernhard, Sonja Dargatz et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft Open access	Aug 2022	59
27	Eveningness and poor sleep quality independently contribute to self-reported depression severity in psychiatric inpatients with affective disorder Matthias Johannes Müller, Bernd Kundermann, Nicole Cabanel · Nordic Journal of Psychiatry	4 Dec 2015	59
28	Cost and Care of Patients with Alzheimer's Disease: Clinical Predictors in German Health Care Settings Jens Peter Reese, Philipp Heßmann, Greta Seeberg et al. · Journal of Alzheimer s Disease	12 Dec 2011	55
29	Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection Ansgar Klimke, Gudrun Hefner, B. Will et al. · Medical Hypotheses Open access	27 Apr 2020	54
30	Case Report: Successful Treatment of Therapy-Resistant OCD With Application of Transcranial Alternating Current Stimulation (tACS) Ansgar Klimke, Michael Andreas Nitsche, Konrad Maurer et al. · Brain stimulation Open access	10 Mar 2016	54
31	Polypharmacy and the risk of drug–drug interactions and potentially inappropriate medications in hospital psychiatry Jan Wolff, Gudrun Hefner, Claus Normann et al. · Pharmacoepidemiology and Drug Safety Open access	19 Jun 2021	52
32	Health-Related Quality of Life in Patients with Alzheimer’s Disease in Different German Health Care Settings Philipp Heßmann, Greta Seeberg, Jens Peter Reese et al. · Journal of Alzheimer s Disease	15 Mar 2016	51
33	Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs Georgios Schoretsanitis, Pierre Baumann, Andreas Conca et al. · Therapeutic Drug Monitoring Open access	20 Nov 2020	50
34	Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs—Influence of Smoking Behavior and Inflammation on Pharmacokinetics Nicole Moschny, Gudrun Hefner, R. Grohmann et al. · Pharmaceuticals Open access	27 May 2021	46
35	Helplessness and perceived pain intensity: relations to cortisol concentrations after electrocutaneous stimulation in healthy young men Matthias Johannes Müller · BioPsychoSocial Medicine Open access	2011	46
36	Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines Ulrich W. Preuss, Euphrosyne Gouzoulis‐Mayfrank, Ursula Havemann‐Reinecke et al. · European Archives of Psychiatry and Clinical Neuroscience	24 Apr 2017	45
37	Rate and predictors of negative effects of psychotherapy in psychiatric and psychosomatic inpatients Julia Rheker, Sylvia Beisel, Svenja Kräling et al. · Psychiatry Research	23 Apr 2017	45
38	Using the HCR-20 to Predict Aggressive Behavior among Men with Schizophrenia Living in the Community: Accuracy of Prediction, General and Forensic Settings, and Dynamic Risk Factors Steven F. Michel, Muhammad Ali Riaz, Christopher Webster et al. · International Journal of Forensic Mental Health	2013	45
39	QLiS – development of a schizophrenia-specific quality-of-life scale Michael Franz, Michael E. Fritz, B. Gallhofer et al. · Health and Quality of Life Outcomes Open access	7 Jun 2012	44
40	Will it hurt less if I believe I can control it? Influence of actual and perceived control on perceived pain intensity in healthy male individuals: a randomized controlled study Matthias Johannes Müller · Journal of Behavioral Medicine	4 Oct 2011	44
41	Factor analyses of multidimensional symptoms in a large group of patients with major depressive disorder, bipolar disorder, schizoaffective disorder and schizophrenia Frederike Stein et al. · Schizophrenia Research	17 Mar 2020	43
42	Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years Stefanie Wagner, Daniel Wollschläger, Nadine Dreimüller et al. · Comprehensive Psychiatry Open access	28 Feb 2020	42
43	Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression Elisabeth Schramm et al. · Psychotherapy and Psychosomatics Open access	2019	41
44	Reliability and Validity of the German Version of the Schema Mode Inventory Neele Reiß, Pauline Dominiak, Dawn Harris et al. · European Journal of Psychological Assessment	21 Dec 2011	41
45	Driving performance in adults with ADHD: Results from a randomized, waiting list controlled trial with atomoxetine Esther Sobanski, D. Sabljic, Barbara Alm et al. · European Psychiatry	10 Oct 2012	41
46	Rates and predictors of remission in first-episode schizophrenia within 1 year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia Wolfgang Gäebel, Mathias Riesbeck, Wolfgang Wölwer et al. · Schizophrenia Research	May 2013	40
47	Response inhibition and impulsive decision-making in sexual offenders against children. Daniel S. Turner, Christian Laier, Matthias Brand et al. · Journal of Abnormal Psychology	31 May 2018	39
48	Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi‐centre study Claudia Zeidler et al. · Journal of the European Academy of Dermatology and Venereology Open access	12 Mar 2024	38
49	Treating alcoholism reduces financial burden on care‐givers and increases quality‐adjusted life years Hans Joachim Salize, Christian Olaf Jacke, Sven Kief et al. · Addiction	25 Sep 2012	38
50	Potential Cost-effectiveness of Therapeutic Drug Monitoring for Depressed Patients Treated With Citalopram Elnaz Ostad Haji, Klaus Mann, Aleksandra Dragičević et al. · Therapeutic Drug Monitoring	10 May 2013	38

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.